NCT01542710

Brief Summary

The purpose of this study is to compare 2 fixed combination medications in intraocular pressure lowering.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 6, 2012

Completed
25 days until next milestone

First Posted

Study publicly available on registry

March 2, 2012

Completed
Last Updated

March 2, 2012

Status Verified

January 1, 2011

Enrollment Period

11 months

First QC Date

February 6, 2012

Last Update Submit

March 1, 2012

Conditions

Glaucoma

Outcome Measures

Primary Outcomes (1)

  • Percentage of drop of intraocular pressures from baseline.

    1 year

Study Arms (1)

Glaucoma fixed Combination Medications

EXPERIMENTAL
Drug: GanfortDrug: Duotrav

Interventions

GanfortDRUG

Bimatoprost/Timolol fixed combination

Also known as: Bimatoprost/Timolol vs Travoprost/Timolol fixed combination
Glaucoma fixed Combination Medications
DuotravDRUG

Fixed combination of Travoprost and Timolol

Glaucoma fixed Combination Medications

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Glaucoma

You may not qualify if:

  • No other ocular diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr El Aini Hospital

Cairo, Egypt

Location

MeSH Terms

Conditions

Glaucoma

Interventions

GanfortBimatoprostDuotrav

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Intervention Hierarchy (Ancestors)

AmidesOrganic ChemicalsCloprostenolProstaglandins F, SyntheticProstaglandins, SyntheticProstaglandinsEicosanoidsFatty Acids, UnsaturatedFatty AcidsLipidsAutacoidsInflammation MediatorsBiological Factors

Study Officials

  • Tamer A Macky, MD FRCS

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 6, 2012

First Posted

March 2, 2012

Study Start

January 1, 2011

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

March 2, 2012

Record last verified: 2011-01

Locations

EG(1)